Hyperthermia has been shown in clinical trials to strongly enhance therapeutic efficacy of radio- and chemotherapy. The main challenge in hyperthermia is to achieve spatially homogenous temperatures between about 41-43 oC for ca. one hour. Magnetic Resonance Imaging-guided High Intensity Focussed Ultrasound (MR-HIFU) enables heating of tissues with high spatial accuracy. We developed a new regulatory algorithm based on Model Predictive Control (MPC) for stable MR-HIFU-hyperthermia, which is designed to find effective heating patterns based on predictions of the temperature evolution in tissue. A comparison with the currently available controller is presented, detailing advantages, shortcomings and opportunities.
Control Algorithm
The MPC algorithm optimizes sonication patterns, aiming to heat the target tissue to a user-specified temperature range. This is done via constrained optimization: The controller uses a system of linear difference equations (LDE) to predict the evolution of temperature in response to heating. The LDE system (‘the model’) is derived from the Pennes bioheat transfer equation, describing the dependency of temperature change from diffusion, perfusion and heating. The cost function to be optimized reflects the difference between the actual temperature and the target temperature range (Figure 1). For the optimization, the algorithm varies heat delivery to a set of target points and uses the model to find the sonication pattern which will lead to the most favorable temperature distribution. The PRFS temperature readout from the MRI functions as feedback to update the controller’s thermal model.
Setup
To accommodate the treatment planning tools required for this algorithm, we developed a custom MR-HIFU control software using pyMRI and pyHIFU for communication with the MR-HIFU hardware5 (Figure 2). Gurobi was used as the optimization engine6. The used hardware was a commercially available 3T MRI (Achieva®, Philips Healthcare) with an integrated HIFU table (Sonalleve®, Profound Medical).
Experiment
The controller’s performance was compared with the commercially available Sonalleve Hyperthermia algorithm. The target was a Polyacrylamide phantom. The output power was limited to 60W and the target temperature increase was set to 5K for the Sonalleve algorithm while the target temperature range was 4K to 6K increase for the MPC controller. The diameter of the target heating area was 18mm for the Sonalleve algorithm and 20mm for the MPC algorithm. The maximum beam deflection was 9mm in both cases. The thermal properties of the phantom were assumed to be similar to muscle.
1. Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem B, Berard L. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncology 2010; 28(5):447-452.
2. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Schlag PM. Hyperthermia in combined treatment of cancer. The Lancet Oncology 2002;3(8):487–497.
3. Tillander, M., Hokland, S., Koskela, J., Dam, H., Andersen, N. P., Pedersen, M., Köhler, M. High intensity focused ultrasound induced in vivo large volume hyperthermia under 3D MRI temperature control. Medical Physics 2016;43(3):1539-1549.
4. Lee, J. H. Model predictive control: Review of the three decades of development. International Journal of Control, Automation and Systems 2011;9(3):415–424.
5. Zaporzan B, Waspe AC, Looi T, Mougenot C, Partanen A, Pichardo S. MatMRI and MatHIFU: software toolboxes for real-time monitoring and control of MR-guided HIFU. Journal of Therapeutic Ultrasound 2013;1(7)
6. Gurobi Optimization Inc.. Gurobi Optimizer Reference Manual. 2016 http://www.gurobi.com. Accessed November 8, 2017